Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
3.30%
↑ 103% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
-97.59%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.30% | +122.7% |
| 2024 | -14.54% | +80.2% |
| 2023 | -73.23% | +54.1% |
| 2022 | -159.42% | +53.3% |
| 2021 | -341.66% | - |
| 2020 | 0.00% | - |